Kyle Kline sold $1.7M of GMED
Senior Vice President, CFO at GLOBUS MEDICAL INC. 18,542 shares at an average of $90.00, traded Dec 1, 2025, filed Dec 3, 2025.
Score components
- +22RoleCFO
- +25Trade size$1.7M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.5%, 3m +3.1%, 6m -11.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-307215, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2025 | MOption exercise Class A Common Stock10b5-1 | +3,646 | $53.14 | $194k | 3,646 | Dec 3, 2025 |
| Dec 1, 2025 | MOption exercise Class A Common Stock10b5-1 | +5,000 | $56.43 | $282k | 8,646 | Dec 3, 2025 |
| Dec 1, 2025 | MOption exercise Class A Common Stock10b5-1 | +5,000 | $64.44 | $322k | 13,646 | Dec 3, 2025 |
| Dec 1, 2025 | MOption exercise Class A Common Stock10b5-1 | +4,896 | $63.68 | $312k | 18,542 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -18,542 | $90.00 | $1.7M | 0 | Dec 3, 2025 |
| Dec 1, 2025 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -3,646 | $0.00 | $0 | 1,354 | Dec 3, 2025 |
| Dec 1, 2025 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -5,000 | $0.00 | $0 | 10,000 | Dec 3, 2025 |
| Dec 1, 2025 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -5,000 | $0.00 | $0 | 0 | Dec 3, 2025 |
| Dec 1, 2025 | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -5,000 | $0.00 | $0 | 0 | Dec 3, 2025 |
Related signals
Other insiders at GLOBUS MEDICAL INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | GMEDsell GLOBUS MEDICAL INC | James R Tobin director | $2.2M 30,000 shares | -100% | |
| 45Moderate | GMEDsell GLOBUS MEDICAL INC | Stephen T Zarrilli director | $2.2M 25,000 shares | -100% | |
| 25Weak | GMEDsell GLOBUS MEDICAL INC | David D Davidar director | $2.0M 25,000 shares | -5% | |
| 25Weak | GLOBUS MEDICAL INC | Kelly Huller EVP, GC, Corporate Secretary | $1.9M 20,000 shares | -100% | |
| 23Weak | GLOBUS MEDICAL INC | Kelly Huller EVP, GC, Corporate Secretary | $877k 10,000 shares | -100% | |
| 20Weak | GLOBUS MEDICAL INC | Leslie Norwalk V director | $202k 2,000 shares | -16% | |
| 30Weak | GLOBUS MEDICAL INC | Kyle Kline Senior Vice President, CFO | $363k 3,594 shares | -100% | |
| 23Weak | GLOBUS MEDICAL INC | Leslie Norwalk V director | $355k 4,000 shares | -24% | |
| 35Weak | GLOBUS MEDICAL INC | Kelly Huller SVP, GC, Corporate Secretary | $675k 7,500 shares | -100% | |
| 40Moderate | GLOBUS MEDICAL INC | David D Davidar director | $2.2M 25,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.